Dosage and administration
Three sprays per day. Hold in mouth for two minutes.
Three sprays per day. Hold in mouth for two minutes.
Dehydroepiandrosterone (DHEA) 8X, Estradiol 8X, Hypophysis Suis 8X, Pregnenolone 8X, Progesterone 8X, Spleen (Bovine) 8X, Testosterone 8X, Thymus (Suis) 8X, Thyroidinum (Suis) 8X, 12X.
For temporary relief of weakness after flu or viral infection, for fortifying spleen and thymus and general revitalization.
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Three sprays per day. Hold in mouth for two minutes.
For temporary relief of weakness after flu or viral infection, for fortifying spleen and thymus and general revitalization.
Citric Acid, Demineralized Water, Ethanol 0.095%, Glycerin, Sodium Benzoate.
Distributed by:
BioActive Nutritional, Inc.
1803 N. Wickham Rd.
Melbourne, FL 32935
bioactivenutritional.com
BIOActive Nutritional
IMMUNE FORTE
HOMEOPATHIC
1 FL OZ (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43857-0166-1 | 2024-08-29 | C162847 | 48780-1 | 9d75b9d0-5ffe-f424-e053-dadaa90a57ce | DRUG FACTS: |
| 43857-0166-1 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d0-5ffe-f424-e053-dadaa90a57ce | DRUG FACTS: |
| 43857-0166-1 | 2022-01-22 | C162847 | 48780-1 | 9d75b9d0-5ffe-f424-e053-dadaa90a57ce | DRUG FACTS: |
| 43857-0166-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5ffe-f424-e053-dadaa90a57ce | DRUG FACTS: |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43857-0166-1 | Immune Forte | 30 mL in 1 BOTTLE, SPRAY | LIQUID | 30 | 6 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43857-0166 | IMMUNE FORTE (DEHYDROEPIANDROSTERONE (DHEA), ESTRADIOL, HYPOPHYSIS SUIS, PREGNENOLONE, PROGESTERONE, SPLEEN (BOVINE), TESTOSTERONE, THYMUS (SUIS), THYROIDINUM (SUIS)) LIQUID [BIOACTIVE NUTRITIONAL, INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20240830_9c355245-260a-464b-abcf-95416b49caa3.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BOS TAURUS SPLEEN | ACTIVE INGREDIENT | 190Q9MB3U3 | 1 | |
| ESTRADIOL | ACTIVE INGREDIENT | 4TI98Z838E | 1 | |
| PRASTERONE | ACTIVE INGREDIENT | 459AG36T1B | 1 | |
| PREGNENOLONE | ACTIVE INGREDIENT | 73R90F7MQ8 | 1 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 1 | |
| SUS SCROFA THYMUS | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | 1 | |
| THYROID, PORCINE | ACTIVE INGREDIENT | 6RV024OAUQ | 1 | |
| BOS TAURUS SPLEEN | ACTIVE MOIETY | 190Q9MB3U3 | 1 | |
| ESTRADIOL | ACTIVE MOIETY | 4TI98Z838E | 1 | |
| PRASTERONE | ACTIVE MOIETY | 459AG36T1B | 1 | |
| PREGNENOLONE | ACTIVE MOIETY | 73R90F7MQ8 | 1 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 1 | |
| SUS SCROFA THYMUS | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| SUS SCROFA THYROID | ACTIVE MOIETY | 6RV024OAUQ | 1 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43857-0166 | 43857-0166-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PRASTERONE | 459AG36T1B | ACTIB |
| ESTRADIOL | 4TI98Z838E | ACTIB |
| SUS SCROFA PITUITARY GLAND | L0PFEMQ1DT | ACTIB |
| PREGNENOLONE | 73R90F7MQ8 | ACTIB |
| PROGESTERONE | 4G7DS2Q64Y | ACTIB |
| BOS TAURUS SPLEEN | 190Q9MB3U3 | ACTIB |
| TESTOSTERONE | 3XMK78S47O | ACTIB |
| SUS SCROFA THYMUS | 7B69B0BD62 | ACTIB |
| THYROID | 6RV024OAUQ | ACTIB |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Immune Forte | DEHYDROEPIANDROSTERONE (DHEA), ESTRADIOL, HYPOPHYSIS SUIS, PREGNENOLONE, PROGESTERONE, SPLEEN (BOVINE), TESTOSTERONE, THYMUS (SUIS), THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 9c355245-260a-464b-abcf-95416b49caa3 | 2024-08-29 | Warnings | 43857-0166-1 43857-0166 43857016601 cabc3e38-84d4-4daa-9121-9ad42ad17b21 9c355245-260a-464b-abcf-95416b49caa3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.